التفاصيل البيبلوغرافية
| العنوان: |
Effect of Liraglutide on Type B Insulin Resistance Syndrome and Insulin Allergy in Type 2 Diabetes: A Case Report. |
| المؤلفون: |
Yuko Matsumoto, Hodaka Yamada, Shunsuke Funazaki, Daisuke Suzuki, Masafumi Kakei, Kazuo Hara |
| المصدر: |
Diabetes Therapy; Oct2017, Vol. 8 Issue 5, p1191-1194, 4p |
| مصطلحات موضوعية: |
INSULIN resistance, DIABETES complications, METABOLIC syndrome, TYPE 2 diabetes, HYPOGLYCEMIC agents, DRUG efficacy |
| مستخلص: |
Introduction: The appearance of anti-insulin antibodies or an allergy to insulin occasionally causes clinical problems with glycemic control in insulin users. Methods: In the present report, we describe a therapeutic approach that was employed for a man with type 2 diabetes who had insulin allergy, anti-insulin antibodies, and anti-insulin receptor antibodies that developed during his insulin treatment. Results: We started the patient on liraglutide, a glucagon-like peptide-1 receptor agonist, and attained glycemic control without incurring any side effects. Two years after liraglutide induction, his blood glucose was being maintained at a healthy level by liraglutide monotherapy. Conclusion: Liraglutide may be a therapeutic option for patients with insulin allergy, anti-insulin antibodies, and type B insulin resistance syndrome, as it represents an alternative strategy to insulin. [ABSTRACT FROM AUTHOR] |
|
Copyright of Diabetes Therapy is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder